Membrane Protein Structures

Core Idea

Membrane proteins — receptors, channels, transporters, and enzymes embedded in the lipid bilayer — represent ~30% of all proteins and are the targets of ~60% of approved drugs, yet their structures have been historically difficult to determine because they require a lipid or detergent environment to maintain their native fold. Advances in crystallization in lipidic cubic phase (LCP), the cryo-EM revolution (membrane proteins in detergent micelles, nanodiscs, or liposomes), and the development of thermostabilizing mutations have transformed membrane protein structural biology. Cryo-EM has become the dominant method for large membrane protein complexes, while LCP crystallography remains important for high-resolution structures of smaller membrane proteins like GPCRs.

Explainer

Membrane proteins sit at the interface between structural biology and pharmacology — they are the targets of most drugs but have been among the hardest proteins to study structurally. The lipid bilayer that is their natural home must be replaced with an artificial hydrophobic environment during purification and structural analysis, and finding environments that maintain the protein's native fold, stability, and functional state is a major challenge that has driven decades of methodological innovation.

Crystallographic approaches for membrane proteins have evolved from detergent-based crystallization (growing crystals from detergent-solubilized protein, where the detergent micelle mediates crystal contacts) to lipidic cubic phase (LCP) crystallization (embedding the protein in a bicontinuous lipid phase that provides membrane-like environment and facilitates crystal nucleation). LCP crystallography, pioneered by Ehud Landau and Martin Caffrey, has been particularly successful for GPCRs and other small membrane proteins, producing the highest-resolution structures. The method uses monoolein as the lipid host, forming a cubic phase that allows protein molecules to diffuse in two dimensions and nucleate into type I (stacked bilayer) crystals.

Cryo-EM has transformed membrane protein structural biology even more dramatically than it has for soluble proteins. Membrane proteins can be imaged in detergent micelles, amphipol belts, lipid nanodiscs, or even reconstituted liposomes. Nanodiscs are particularly attractive because they provide a defined, native-like lipid bilayer environment: the protein sits in a small disc of membrane surrounded by scaffold proteins, maintaining the lateral pressure, bilayer thickness, and lipid interactions of the native membrane. Cryo-EM of membrane proteins in nanodiscs has revealed structures of ion channels, transporters, and receptor complexes with endogenous lipids resolved at the protein-lipid interface — information critical for understanding how the lipid environment modulates protein function.

The biological impact has been enormous. GPCR structural biology has progressed from a single structure (rhodopsin, 2000) to hundreds of structures in multiple functional states (inactive, active, G protein-bound, arrestin-bound), revealing the conserved mechanisms of receptor activation and the structural basis of drug selectivity. Ion channel structures (Kv, Nav, TRP, ligand-gated channels) have explained selectivity, gating, and drug binding at atomic resolution. Transporter structures (ABC transporters, SLC carriers, P-type ATPases) captured in different conformational states have revealed the alternating-access mechanism. Each of these advances was enabled by methodological innovation in membrane protein handling — finding the right detergent, the right lipid environment, or the right stabilization strategy. The lesson is that structural biology of membrane proteins is as much about biochemistry and sample preparation as it is about data collection and computation.